Multiple components in serum contribute to hepatic transgene expression by lipoplex in mice

Journal of Gene Medicine

Volumn 13, Issue 11, 2011, Pages 632-643

  Yoshikawa, Naoki ^a   Sakamoto, Keiko ^a   Mizuno, Sachiyo ^a   Sakaguchi, Junichiro ^a   Miyamoto, Hirotaka ^a   Mine, Toyoharu ^a   Sasaki, Hitoshi ^b   Fumoto, Shintaro ^a   Nishida, Koyo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cationic liposomes; Gene therapy; Interaction; Lipoplex; Serum components

Indexed keywords

ANION; BOVINE SERUM ALBUMIN; CALCIUM ION; COMPLEMENT COMPONENT C3; FIBRONECTIN; LIPOPLEX; PLASMID DNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; ANTIPORTERS; CALCIUM; CATIONS, DIVALENT; CHROMATOGRAPHY, ION EXCHANGE; COMPLEMENT C3; DNA; EDETIC ACID; FIBRONECTINS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; LIPOSOMES; MALE; MEMBRANE FUSION; MICE; PLASMIDS; SERUM; TRANSFECTION; TRANSGENES;

EID: 82455186764     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1618     Document Type: Article

References (61)

1. Griffith TS, Stokes B, Kucaba TA, et al. TRAIL gene therapy: from preclinical development to clinical application. Curr Gene Ther 2009; 9: 9-19.
2. Guinn BA, Mulherkar R. International progress in cancer gene therapy. Cancer Gene Ther 2008; 15: 765-775.
3. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008; 29: 3477-3496.
4. Tan MH, Smith AJ, Pawlyk B, et al. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Hum Mol Genet 2009; 18: 2099-2114.
5. Mclean JW, Thurstin G, McDonald DM. Site of uptake and expression of cationic liposome/DNA complexes injected intravenously. In Nonviral Vectors for Gene Therapy, Huang L, Hung M-C, Wagner E (eds). Academic Press, Inc.: San Diego, CA, 1999; 120-134.
6. Yang JP, Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther 1997; 4: 950-960.
7. Sakurai F, Nishioka T, Saito H, et al. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Ther 2001; 8: 677-686.
8. Fumoto S, Kawakami S, Shigeta K, Higuchi Y, Yamashita F, Hashida M. Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex. J Pharmacol Exp Ther 2005; 315: 484-493.
9. Sakurai F, Nishioka T, Yamashita F, Takakura Y, Hashida M. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system. Eur J Pharm Biopharm 2001; 52: 165-172.
10. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm Res 2000; 17: 306-313.
11. Lee HG, Lee JS, Choi MJ, Choe IS, Chung TW. Purification and characterization of human complement component C3. Korean Biochem J 1990; 23: 128-134.
12. Lausted C, Hu Z, Hood L. Quantitative serum proteomics from surface plasmon resonance imaging. Mol Cell Proteomics 2008; 7: 2464-2474.
13. Jahnen-Dechent W, Schinke T, Trindl A, et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997; 272: 31496-31503.
14. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993; 119: 1079-1091.
15. Sotogaku N, Oku N, Takeda A. Manganese concentration in mouse brain after intravenous injection. J Neurosci Res 2000; 61: 350-356.
16. Kim KA, Lee EY, Kang JH, et al. Diagnostic accuracy of serum asialo-alpha1-acid glycoprotein concentration for the differential diagnosis of liver cirrhosis and hepatocellular carcinoma. Clin Chim Acta 2006; 369: 46-51.
17. Markiewski MM, Mastellos D, Tudoran R, et al. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 2004; 173: 747-754.
18. Fumoto S, Kawakami S, Ito Y, Shigeta K, Yamashita F, Hashida M. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. Mol Ther 2004; 10: 719-729.
19. Nguyen TH, Ferry N. Liver gene therapy: advances and hurdles. Gene Ther 2004; 11: S76-84.
20. Hwang LH. Gene therapy strategies for hepatocellular carcinoma. J Biomed Sci 2006; 13: 453-468.
21. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244-2245.
22. Tousignant JD, Gates AL, Ingram LA, et al. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum Gene Ther 2000; 11: 2493-2513.
23. Kawakami S, Yamashita F, Nishikawa M, Takakura Y, Hashida M. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem Biophys Res Commun 1998; 252: 78-83.
24. Chonn A, Semple SC, Cullis PR. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem 1992; 267: 18759-18765.
25. Patel HM. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst 1992; 9: 39-90.
26. McManus LM, Nakane PK. Isolation and characterization of mouse C1q. J Immunol Methods 1980; 36: 159-171.
27. Ishida T, Harashima H, Kiwada H. Liposome clearance. Biosci Rep 2002; 22: 197-224.
28. Hamuro J, Hadding U, Bitter-Suermann D. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities. J Immunol 1978; 120: 438-444.
29. Rivedal E. Role of plasma fibronectin in the morphological transformation of hamster embryo cells. Cancer Lett 1982; 17: 9-17.
30. Ferguson JS, Weis JJ, Martin JL, Schlesinger LS. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun 2004; 72: 2564-2573.
31. Barron LG, Meyer KB, Szoka FC Jr. Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum Gene Ther 1998; 9: 315-323.
32. Barron LG, Gagné L, Szoka FC Jr. Lipoplex-mediated gene delivery to the lung occurs within 60min of intravenous administration. Hum Gene Ther 1999; 10: 1683-1694.
33. Sakurai F, Terada T, Yasuda K, Yamashita F, Takakura Y, Hashida M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther 2002; 9: 1120-1126.
34. Sutterwala FS, Rosenthal LA, Mosser DM. Cooperation between CR1 (CD35) and CR3 (CD 11b/CD18) in the binding of complement-opsonized particles. J Leukoc Biol 1996; 59: 883-890.
35. Pan ZK. Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes. Biochim Biophys Acta 1998; 1443: 90-98.
36. Kako K, Nishikawa M, Yoshida H, Takakura Y. Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice. J Pharm Sci 2008; 97: 3074-3083.
37. Mori S, Itoh Y, Shinohata R, Sendo T, Oishi R, Nishibori M. Nafamostat mesilate is an extremely potent inhibitor of human tryptase. J Pharmacol Sci 2003; 92: 420-423.
38. Li Q, Nacion K, Bu H, Lin F. The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am J Pathol 2009; 175: 661-667.
39. Kumagai H, Tajima M, Ueno Y, Giga-Hama Y, Ohba M. Effect of cyclic RGD peptide on cell adhesion and tumor metastasis. Biochem Biophys Res Commun 1991; 177: 74-82.
40. Johansson S, Forsberg E, Lundgren B. Comparison of fibronectin receptors from rat hepatocytes and fibroblasts. J Biol Chem 1987; 262: 7819-7824.
41. Scoazec JY, Flejou JF, D'Errico A, et al. Focal nodular hyperplasia of the liver: composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules. Hum Pathol 1995; 26: 1114-1125.
42. Jersmann HP, Dransfield I, Hart SP. Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci 2003; 105: 273-278.
43. Nagayama S, Ogawara K, Minato K, et al. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int J Pharm 2007; 329: 192-198.
44. Arangoa MA, Düzgüneş N, Tros de Ilarduya C. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes. Gene Ther 2003; 10: 5-14.
45. Wu J, Liu P, Zhu JL, Maddukuri S, Zern MA. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology 1998; 27: 772-778.
46. Tros de Ilarduya C, Arangoa MA, Moreno-Aliaga MJ, Düzgüneş N. Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes. Biochim Biophys Acta 2002; 1561: 209-221.
47. Tandia BM, Vandenbranden M, Wattiez R, Lakhdar Z, Ruysschaert JM, Elouahabi A. Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer. Mol Ther 2003; 8: 264-273.
48. Tandia BM, Lonez C, Vandenbranden M, Ruysschaert JM, Elouahabi A. Lipid mixing between lipoplexes and plasma lipoproteins is a major barrier for intravenous transfection mediated by cationic lipids. J Biol Chem 2005; 280: 12255-12261.
49. Rahman YE, Cerny EA, Patel KR, Lau EH, Wright BJ. Differential uptake of liposomes varying in size and lipid composition by parenchymal and kupffer cells of mouse liver. Life Sci 1982; 31: 2061-2071.
50. Ogawara K, Yoshida M, Higaki K, et al. Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. J Control Release 1999; 59: 15-22.
51. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 1970; 31: 125-150.
52. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985; 5: 683-692.
53. Gatmaitan Z, Varticovski L, Ling L, Mikkelsen R, Steffan AM, Arias IM. Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol 1996; 148: 2027-2041.
54. Ross PC, Hui SW. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther 1999; 6: 651-659.
55. Turek J, Dubertret C, Jaslin G, Antonakis K, Scherman D, Pitard B. Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection. J Gene Med 2000; 2: 32-40.
56. Higuchi Y, Kawakami S, Fumoto S, Yamashita F, Hashida M. Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration. Biol Pharm Bull 2006; 29: 1521-1523.
57. Fumoto S, Nakadori F, Kawakami S, Nishikawa M, Yamashita F, Hashida M. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver. Pharm Res 2003; 20: 1452-1459.
58. Fumoto S, Kawakami S, Ishizuka M, Nishikawa M, Yamashita F, Hashida M. Analysis of hepatic disposition of native and galactosylated polyethylenimine complexed with plasmid DNA in perfused rat liver. Drug Metab Pharmacokinet 2003; 18: 230-237.
59. Xu Y, Szoka FC Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996; 35: 5616-5623.
60. Sakurai F, Inoue R, Nishino Y, et al. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. J Control Release 2000; 66: 255-269.
61. Li S, Tseng WC, Stolz DB, Wu SP, Watkins SC, Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 1999; 6: 585-594.